Polak dame julia (29 risultati)

paperback. Condizione: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.

Paperback. Condizione: New. In shrink wrap. Looks like an interesting title.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New. pp. 400.

Condizione: New. pp. xv + 176 3rd Edition.

Condizione: As New. Unread book in perfect condition.

hardcover. Condizione: Very Good. Ex-Library copy. Orders shipped daily from the UK. Professional seller.

Condizione: New.

Condizione: New. pp. 400.

Condizione: New.

Paperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.

Kartoniert / Broschiert. Condizione: New.

Condizione: New. pp. 400.

Condizione: New. In English.

Paperback. Condizione: Brand New. 3rd edition. 192 pages. 9.00x6.00x0.50 inches. In Stock.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Paperback. Condizione: Brand New. 400 pages. 9.21x6.14x1.02 inches. In Stock.

Paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: New. Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It is suitable for those within the healthcare sector interested in investing in the delivery of regenerative medicines to the benefit of patients. Editor(s): Prescott, Catherine; Polak, Dame Julia. Num Pages: 400 pages, 17 black & white illustrations, 32 black & white tables. BIC Classification: MBP; MMG. Category: (UP) Postgraduate, Research & Scholarly. Dimension: 240 x 166 x 28. Weight in Grams: 760. . 2010. 1st Edition. hardcover. . . . .…

Hardcover. Condizione: new. Hardcover. Now that prohibitions against stem cell research are relaxing, it is time for the field to move forward with the advances that promise to eliminate so much human suffering. However, it would be naive to ignore the fact that regenerative medicines pose a whole new set of challenges to an industry sector that for decades has geared itself to the development and delivery of traditional pharmaceuticals. Still, significant strides are being made. Unique in its focus, The Delivery of Regenerative Medicines and Their Impact on Healthcare delves into material not included in other books. Edited by Dr. Catherine Prescott and Professor Dame Julia Polak, two of the most respected authorities in stem cell research and the business of regenerative medicine, this text presents original firsthand accounts of experts from around the globe. Professor Polak starts by summarizing the progress made and the challenges currently facing the field both as a science and an emerging industry. This is followed by topics relevant to regulators, insurers, and investors as well as pharmaceutical and biotech researchers.Offering innovative insight on topics rarely covered, this volume: Details various innovative investment models Offers a detailed overview of cell-based products and therapeutic stem cell technologies Examines concerns over safeguarding intellectual property Looks at evolving regulations in the U.S. and Europe Discusses insurance and risk management and the establishment of reimbursement parameters This book reaches out to inform a wide audience across government, industry, and academia. It goes beyond the usual discussions to help invigorate the dialogue and present solutions that must occur at the crossroads of technology and commerce for regenerative medicines to realize their promise. Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It is suitable for those within the healthcare sector interested in investing in the delivery of regenerative medicines to the benefit of patients. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condizione: New.

Condizione: New. Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It is suitable for those within the healthcare sector interested in investing in the delivery of regenerative medicines to the benefit of patients. Editor(s): Prescott, Catherine; Polak, Dame Julia. Num Pages: 400 pages, 17 black & white illustrations, 32 black & white tables. BIC Classification: MBP; MMG. Category: (UP) Postgraduate, Research & Scholarly. Dimension: 240 x 166 x 28. Weight in Grams: 760. . 2010. 1st Edition. hardcover. . . . . Books ship from the US and Ireland.…

Hardcover. Condizione: Brand New. 1st edition. 400 pages. 9.49x6.42x1.10 inches. In Stock.

Hardcover. Condizione: new. Hardcover. Now that prohibitions against stem cell research are relaxing, it is time for the field to move forward with the advances that promise to eliminate so much human suffering. However, it would be naive to ignore the fact that regenerative medicines pose a whole new set of challenges to an industry sector that for decades has geared itself to the development and delivery of traditional pharmaceuticals. Still, significant strides are being made. Unique in its focus, The Delivery of Regenerative Medicines and Their Impact on Healthcare delves into material not included in other books. Edited by Dr. Catherine Prescott and Professor Dame Julia Polak, two of the most respected authorities in stem cell research and the business of regenerative medicine, this text presents original firsthand accounts of experts from around the globe. Professor Polak starts by summarizing the progress made and the challenges currently facing the field both as a science and an emerging industry. This is followed by topics relevant to regulators, insurers, and investors as well as pharmaceutical and biotech researchers.Offering innovative insight on topics rarely covered, this volume: Details various innovative investment models Offers a detailed overview of cell-based products and therapeutic stem cell technologies Examines concerns over safeguarding intellectual property Looks at evolving regulations in the U.S. and Europe Discusses insurance and risk management and the establishment of reimbursement parameters This book reaches out to inform a wide audience across government, industry, and academia. It goes beyond the usual discussions to help invigorate the dialogue and present solutions that must occur at the crossroads of technology and commerce for regenerative medicines to realize their promise. Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It is suitable for those within the healthcare sector interested in investing in the delivery of regenerative medicines to the benefit of patients. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Condizione: New. Print on Demand pp. xv + 176 Illus. This item is printed on demand.

Condizione: New. PRINT ON DEMAND pp. xv + 176.

Condizione: New. pp. 400 This item is printed on demand.